65,437 trials
Facial Skin Laxity
Primary: Number of Participants With Improvement in Skin Laxity in Submental Region and Neck at Day 90 — 8 Participants
GERD Gastroesophageal Reflux Disease
Primary: Elimination of Moderate-severe Regurgitation at 6 Months — 10; 42 Participants
Cardiac Arrest
Primary: Number of Patients Alive at 72 Hours After Episode. — 230; 275 Participants
Arrhythmias, Cardiac
Primary: Device Malfunction — 24; 52 Participants
Severe Mental Illness · Nicotine Dependence · Schizophrenia
Primary: Initiation of Smoking Cessation Treatment — 14; 24 participants — p=0.08
Idiopathic Intracranial Hypertension
Primary: Mean Change in Perimetric Mean Deviation — 1.43; 0.71 dB — p=0.05
Breast Cancer
Primary: Number of Participants Who Experienced Toxicity to the Vaccine — 0; 0 Participants
Spondylitis, Ankylosing
Primary: Number of Participants With 20% Improvement in the Assessment of Spondyloarthritis International Society Criteria Scale / ASAS 20 Response — 43; 46; 28; 31 Participants…
Cannabis Dependence
Primary: Reduction in Mean Number of Days of Cannabis Use Per Week — 4.1; 3.1 days of use per week
Weight Gain During Pregnancy
Primary: Count of Women Who Have Excess Gestational Weight Gain — 10; 11; 11 Participants
Stress Urinary Incontinence
Primary: Symptoms of Urinary Incontinence at Baseline and at 6 Weeks — 27.5; 1.1 score on a scale — p=0.0001
Postmenopausal Women With Osteoporosis
Primary: Percentage of Participants With New Vertebral Fractures Through Month 24 — 8.0; 4.1 percentage of participants — p=<0.001
HIV
Primary: CIAS (Computerized Intervention Authoring Software) Satisfaction Measure Scores to Assess the Feasibility and Acceptability of the Computer and HCEM Software — 4.8; 6.6…
Chronic Low Back Pain
Primary: Change in Heart Rate Variability Before and After 40-minute Stimulation — 0.206; -0.01 ms^2 — p=.319
HIV-1
Primary: Percentage of Participants With Clonal Expansion of Cells With a Predominant OZ1 Insertion Site — 0 Percentage of participants